Iolanda F L C Tibério Selected Research

Iolanda F L C Tibério Research Topics

Disease

21	Pneumonia (Pneumonitis) 08/2021 - 10/2006
19	Inflammation (Inflammations) 08/2021 - 04/2005
12	Asthma (Bronchial Asthma) 10/2020 - 10/2005
5	Emphysema 01/2021 - 03/2014
5	Edema (Dropsy) 01/2021 - 10/2005
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 10/2016
3	Lung Diseases (Lung Disease) 01/2021 - 05/2007
3	Respiratory Hypersensitivity 10/2020 - 01/2011
2	Pulmonary Emphysema 01/2021 - 10/2016
2	Acute Lung Injury 02/2017 - 01/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2017 - 03/2014
2	Airway Remodeling 01/2011 - 10/2005
1	Pulmonary Edema 08/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Vascular Remodeling 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 11/2019
1	Hypersensitivity (Allergy) 01/2018
1	Cough 08/2010
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2007

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 08/2021 - 09/2012
6	Cholinergic Agents (Cholinergics)IBA 08/2021 - 01/2015
6	CollagenIBA 01/2021 - 10/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2013 - 10/2005
3	Acetylcholine (Acetylcholine Chloride)FDA Link 08/2021 - 09/2020
3	Pancreatic Elastase (Elastase)IBA 01/2021 - 10/2016
3	LipopolysaccharidesIBA 01/2021 - 02/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2015
3	OvalbuminIBA 09/2020 - 01/2019
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2012 - 04/2005
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2008 - 10/2005
2	Proteins (Proteins, Gene)FDA Link 08/2021 - 01/2020
2	Cholinergic ReceptorsIBA 08/2021 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2015
2	EugenolIBA 01/2021 - 10/2020
2	Biological ProductsIBA 10/2020 - 03/2014
2	PNU-282987IBA 09/2020 - 01/2017
2	InterleukinsIBA 01/2020 - 01/2013
2	rho-Associated KinasesIBA 01/2020 - 01/2018
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 11/2019 - 01/2019
2	sakuranetinIBA 01/2019 - 02/2017
2	FlavonoidsIBA 01/2019 - 03/2014
2	Interleukin-13IBA 01/2015 - 01/2013
2	Methacholine Chloride (Methacholine)FDA Link 01/2015 - 01/2009
2	ArginaseIBA 08/2013 - 01/2011
2	Protein Isoforms (Isoforms)IBA 01/2011 - 10/2006
2	AntigensIBA 01/2009 - 10/2005
2	Nitric Oxide Synthase (NO Synthase)IBA 06/2008 - 10/2006
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	8-epi-prostaglandin F2alphaIBA 01/2021
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	dehydrodieugenol BIBA 01/2021
1	dehydrodieugenolIBA 10/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2020
1	Y 27632IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Fibronectins (Fibronectin)IBA 11/2019
1	ElastinIBA 11/2019
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2019
1	SmokeIBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Neutralizing AntibodiesIBA 01/2018
1	AlbuminsIBA 01/2018
1	Therapeutic UsesIBA 02/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Monoterpenes (Monoterpenoids)IBA 10/2016
1	AntioxidantsIBA 10/2016
1	4-cymene (p-cymene)IBA 10/2016
1	Volatile Oils (Essential Oils)IBA 10/2016
1	carvacrolIBA 10/2016
1	ThymolIBA 10/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2015
1	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 01/2015
1	NF-kappa B (NF-kB)IBA 01/2015
1	Chemotactic FactorsIBA 01/2013
1	CCR ReceptorsIBA 01/2013
1	AllergensIBA 01/2011
1	EnzymesIBA 01/2011
1	Nitric Oxide DonorsIBA 01/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2011
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2010
1	Fluoxetine (Prozac)FDA LinkGeneric 05/2007

Therapy/Procedure

1	Ovariectomy (Oophorectomy) 08/2021
1	Therapeutics 01/2016
1	Immunotherapy 06/2008